I know the IGXT trades are not going to translate into tomorrow, just posted on that on IGXT board, a 2,500 share trade after hours .28 lower than where it was trading most of the day? Not when we are going into profitability, who would sell cheap? The ONCS trade, would seem to follow news, but I don't see any news. There were quite a few trades, some with size, so I won't discount that being real. Good day tomorrow?
This will not change where we are tomorrow, somebody painted the tape, we traded 693,800 shares in the high $0.60's and a 2,500 share short trade after hours comes in a .38, that won't wash, who would sell their shares for that knowing we are coming into profitability?
You are short, either that or you don't want to embrace the many positives that asiepker and I are attempting to articulate here. If we see 41.75 again, it won't last and would likely reverse back up the same day. I'm going to rest my position and let it play out to the upside, then you can concede or develop new theories to bash the stock. We're done here for now.
Sentiment: Strong Buy
Keep up the great posts Prospector, again, and again, and again! Gold veins in this here pipeline! I'd love to sit with many of you, Michael Dell's advisors and/or Randall J. Kirk himself, and have a fireside chat with them and Jeff Riley about forward visions they have for SYN. How can we get MSDC's advisors to post here on the YMB? That would be really fun! If we hit $10 by year end, we'll have to set a meet up in Las Vegas! Get it done Riley!
Sentiment: Strong Buy
It wants to go higher. Just look at the last three trading days. There have been three intra-day spikes over $44, and three others that came close to $44. What is this action telling us? Today we retraced to close $0.32 down, on the worst day for the major indexes in the last 3 months. Seems solid to me, give us a good market day and $44.50-45.00 here we come!
Love that we closed over 13.00 but not going to make any predictions, we've been here and done that before. The more times it happens, the softer the resistance becomes is the way I look at it, we will bust through that ceiling and then get to the $14 handle. Good start on the year, especially against the market headwinds that blew strong today.
Based on a close today, how does that figure into your 'model'? I wouldn't be here if I didn't think we would go higher, much higher, but when posters show up and make these fantastic predictions, and try to even pinpoint when it will happen, to me it's a recipe for the destruction of one's credibility in a hurry, because it usually doesn't happen as they call it. So, my question to you, how did today's close figure into your thinking for timing of the big move?
I posted this once before in early December, but we did sell down to .50 later in the month. Now we are headed back up, having our best day since the spike to .70, on the day when the major indexes are having their worst day in three months. Profitability and analyst upgrades are on the horizon, congrats to those smart enough to have accumulated at lower prices.
Sure am glad I chose healthcare and biotech as my main investment strategy. My portfolio is currently up 1% when the major indexes are having their worst day in three months. Syn up now at 1.59, having touched 1.64. Hold onto your shares, things are only going to get better from here on out.
Love how IDRA is performing, and hope we see good things this year from TROV, where I opened a position today at 5.03. These two stocks are at parity now, it will be interesting to see which one outperforms by year end.
We just got a catalyst, that Afrezza has insurance coverage by one of the largest PBM's, and it will support more buyers getting into MNKD. When SNY announces timing of launch, unless it is pushed out, that should provoke more upside pressure. When we hear good news on manufacturing, more push up in pps. All this could happen any week now. The new year has already shown us there is organic demand for MNKD stock, let's hope we've turned the corner on the 5's for good!
Sentiment: Strong Buy
You mention "high cost of sales" due to partnerships with Stryker and Arthrex? On the contrary, we have no burden of sales costs, as our revenue is in milestones and percentage of sales. It is a difference in perspective I suppose. I am glad they didn't try to go it alone, then our cost of sales would have put us in an entirely different position, with greater risk and longer road to profitability.
$16.50 will look cheap in a very few weeks, I am going to add more shares this coming week. By this time next year, we could be at $35.
More and more of these articles are restricted to only PRO subscribers, and the annual subscription to PRO is bumping up around $1,700 per year. Since they have published so many #$%$ sell-side articles in the past that have hurt me, I refuse to subscribe to their paid site. I'll take your word that it is a balanced good piece, and read what is otherwise available without subscription. Thanks for the post!